A 44-year-old man is presented here with 14 years of chronic purulent sinusitis, a chronic fungal rash of the scrotum, and chronic pelvic pain. Treatment with antifungal therapy resulted in symptom improvement, however he was unable to establish an effective long-term treatment regimen, resulting in debilitating symptoms. He had undergone extensive workup without identifying a clear underlying etiology, although Candida species were cultured from the prostatic fluid. 100 genes involved in the cellular immune response were sequenced and a missense mutation was identified in the Ras-binding domain of PI3Kc. PI3Kc is a crucial signaling element in leukotaxis and other leukocyte functions. We hypothesize that his mutation led to his chronic infections and pelvic pain.
Introduction and Materials and Methods

Case Report
A 44 year-old male presented with 14 years of chronic infections and pelvic pain. Although subject to frequent respiratory and gastrointestinal infections since childhood, his pelvic pain began at age 30. Following initiation of antibiotic and corticosteroid treatment for acute sinusitis, he developed a painful erythematous scrotal rash. His core symptoms are presented in Table S1 . He initially attempted treatment with antifungals with mild improvement, but his rash gradually worsened over time. After another course of antibiotics for acute sinusitis, his rash spread to the glans penis and he subsequently developed severe urethral, testicular, and pelvic pain. He also began having chronic purulent sinusitis, and since that time he has struggled to control his upper respiratory symptoms, pelvic pain, and scrotal rash. The dynamics of his symptoms over time is presented in Figure 1 .
He has undergone treatment with numerous immunologic and antifungal therapies including G-CSF, IFN-gamma, GM-CSF, IVIG, IL-2, fluconazole, amphotericin B, micafungin, itraconazole, caspofungin, voriconazole, with varying levels of success (Figures 2-8 ). He experienced substantial improvement of his pelvic pain and skin lesions and mild improvement of his upper respiratory symptoms with micafungin but had to forego therapy for financial reasons ( Figure 1 and Figure 5 ). Other regimens including GM-CSF (Figure 3 ) with fluconazole and amphotericin ( Figure 2 ) with caspofungin ( Figure 4 ) have also helped control symptoms, but to a lesser degree. He has consistently noted worsening of his pelvic pain, rash, and upper respiratory symptoms with antibiotic treatments. Unfortunately, medication costs and side effects have prohibited the establishment of a successful longterm regimen. His pelvic pain and the fatigue associated with his symptoms have significantly impacted his quality of life. His pelvic pain limits his ability to sit for long periods of time, and his sinusitis is associated with pharyngitis, headaches, fatigue, and malaise. These symptoms have limited his ability to work, exercise, maintain a social life, and enjoy dating or sexual activity.
He has undergone extensive work-up, which has failed to identify a unifying underlying diagnosis (Tables 1, 2, and 3 and  Tables S2, S3, S4) . Prostatic fluid and ejaculate cultures, however, have grown multiple Candida species (Table 4) , and immunologic testing has demonstrated anergy to Candida antigen (Table S3) .
We hypothesized that defects in the cellular immune response may underlie his clinical condition, as we have demonstrated previously in other chronic fungal infections. [1, 2] The current study was approved by the Institutional Review Boards of Children's Hospital Boston, Beth Israel Deaconess Medical Center in Boston and Radboud University in Nijmegen, the Netherlands.
The individual in this manuscript has given written informed consent to publish these case details, as outlined in the PLoS consent form available at: http://www.plosone.org/static/ plos_consent_form.pdf.''
Results
A panel of 100 genes known to induce or modulate the immune response was sequenced, [1] revealing a heterozygous mutation in the gene PIK3CG, corresponding to a Val282Ala amino acid substitution in the phosphatidylinositol-3-kinase gamma (PI3Kc) protein (Tables 5 and 6 , Figures 9 and 10) . The brother and the father of the patient tested negative for this mutation in PIK3CG, suggestive of a de novo mutation. Unfortunately, this could not be definitively confirmed by the DNA analysis of the patient's mother, as she was deceased ( Table 7 ). The mutation is not a known polymorphism, based on its absence in 100 in-house exome datasets from individuals of European ancestry, and from 179 individuals sequenced as part of the 1000 genomes project. [3] Based on a Grantham score of 64, this mutation is predicted to be poorly tolerated for maintaining protein conformation.
Discussion
We present a patient with chronic infections and pelvic pain, found to have a novel missense mutation in PI3Kc: a signaling We hypothesize that the patient's mutation is responsible both for his predisposition to chronic infections and his chronic pelvic pain. Chronic pelvic pain syndrome (CPPS) is defined as greater than three months of pelvic pain over a six month period with no established etiology based on routine testing. [4] Pain symptoms can occur in the perineum, lower abdomen, testicles, penis, and with ejaculation, and patients can also experience voiding dysfunction. CPPS has been estimated to account for nearly two million annual physician visits, [5] and its impact on quality of life is similar to or greater than angina, congestive heart failure, Crohn's disease, and diabetes mellitus. [6] While the etiology and pathophysiology are not well understood, many experts favor a model of CPPS as a heterogeneous condition, with multiple potentially overlapping etiologies existing along a spectrum. This patient's history may suggest a chronic fungal infection, or potentially an autoimmune process precipitated by an inciting fungal infection, as the cause of his CPPS. While infectious and autoimmune mechanisms have been proposed in CPPS, they have never been proven responsible in specific cases. Furthermore, while multiple levels of evidence support a genetic underpinning in CPPS, a specific mutation has never been proven responsible. Recent evidence from the Northwestern University Prostatitis Research group implicates mast cells in the pathogenesis of CPPS. [7, 8] Activation may result in the release of vasoactive and inflammatory molecules in response to unknown triggers. [9] This activation is known to be significantly dependent on PI3K-c. [10] .
Despite a wide range of roles in cells throughout the body, PI3Kc has largely been studied for its importance within the immune system, where it participates in leukotaxis and other elements of the immune response. Class I PI3Ks are heterodimers consisting of a catalytic and a regulatory subunit that is further grouped into Class I A and I B, each with respective isoforms. Class I A PI3Ks are activated by receptor tyrosine kinases (RTKs), whereas class I B is activated through G protein coupled receptors (GPCR). [11, 12] PI3Kc consists of a catalytic subunit, p110c, and Novel PI3K-Gamma Mutation in Chronic Pelvic Pain PLOS ONE | www.plosone.org regulatory subunits, p101 or p84/p87. [13] Upon binding of chemokines or other ligands to GPCRs, PI3Kc is activated through binding to the bc subunit of a heterotrimeric G-protein.
PI3Kc activation is also enhanced by binding of the GTPase Ras to the Ras-binding domain of p110c, which lies directly adjacent to the catalytic domain. [13] This initiates the signaling cascade that results in chemotaxis in multiple leukocyte lineages, both within the adaptive and innate immune responses. In addition, it activates other leukocyte functions, including the oxidative burst in neutrophils. [14] In vivo models have demonstrated decreased inflammation and susceptibility to infections when PI3Kc function is abrogated, making it an attractive target in the treatment of inflammatory, allergic and autoimmune diseases. [14, 15] .
Beer-Hammer and colleagues demonstrated that p110c contributes to T and B cell development, and is variably expressed throughout the hematopoietic process. [16] The c catalytic subunit plays a very different role from other I B class members, directly interacting with the G-protein bc dimers and Ras proteins. Several studies have looked at p110c/p110d mutants p110c-deficient animals, homozygous for a KD p110d mutant, show profound T cell lymphopenia accompanied by multiple organ inflammation, [15, [17] [18] [19] while mutations only in p110c primarily causes defects in neutrophil and mast cell function. [19] These mutations have shown specificity in affecting TCR-induced T cell activation. [18] PI3Kc has been implicated in leukocyte migration, regulation of T-cell proliferation and cytokine release, [10] and most recently mast cell activation. [20] Overexpression of p110c was shown to induce oncogenic transformation of chicken embryo fibroblasts, if Ras binding occurred. [21] P110c overexpression has also been documented in chronic myeloid leukemia, [22] presenting it as an potential oncogene through the recent literature.
The Val282Ala mutation occurs within the Ras-binding domain of the p110c subunit of PI3Kc. Functional studies will be necessary to determine the specific effect of the Val282Ala mutation on the activity of PI3Kc, but one can hypothesize that decreased activity could suppress the immune response by inhibiting leukocyte migration and function. This could explain the patient's history of frequent and chronic infections. Additionally, it could potentially explain his chronic pelvic pain, through several different mechanisms. The history suggests that the patient's cutaneous fungal infection likely spread to the urinary tract after extending to the glans penis, and may have subsequently involved the urethra, epididymis, testicles, prostate, or other areas within the genitourinary system. With failure to completely eradicate the infection due to impaired leukocyte activity, chronic infection alone may have caused his pain symptoms. Another possibility is that the initial infection within the genitourinary system may have been effectively treated by antifungal therapy but subsequently incited an autoimmune process, which can result from infection via multiple mechanisms. [23] Alternatively, a mutation in PI3KCG that resulted in over-activation could cause inflammation through an autoimmune mechanism, resulting in chronic pelvic pain. Further studies will be necessary to determine the activity of the mutant protein and elucidate the exact mechanisms of injury. Novel PI3K-Gamma Mutation in Chronic Pelvic Pain PLOS ONE | www.plosone.org
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